Webinar Sign-Up 8/13/25 - RxSaveCard

Live Webinar: Navigating the GLP-1 Cost Dilemma with Chris Crawford

Employees want access to weight-loss medications.  Employers are struggling to afford them.  Learn how employers are looking outside of their insurance carriers and PBMs to provide access to these high-demand medications.

Days
Hours
Minutes
Seconds

Meet Chris Crawford

Founder & CEO of RxSaveCard

Chris Crawford has always been driven by a simple question: Why should anyone overpay for prescriptions when lower prices are available? After 25+ years in the employee benefits space, he founded RxSaveCard as a solution to that problem.

Webinar Agenda:

The Demand Explosion Creating Budget Crisis

Understand the market forces driving GLP-1 utilization from 8-10% of Americans today to an estimated 40 million Americans by 2029, and how this explosive growth is beginning to impact the budgets of self-insured employers.

Traditional Coverage Model Challenges

Explore the impossible choice employers face: limit utilization and lose valuable rebates, or keep rebates but surrender all control over costs. We'll also discuss major plan changes like CVS Caremark's Zepbound coverage elimination that affected 4.9 million people, and the 62% overall denial rate for GLP-1 prescriptions.

Direct Manufacturing Solutions

Discover how pharmaceutical companies are bypassing insurance with self-pay programs that keep getting cheaper and offering more value. Learn about existing programs from Novo Nordisk and Eli Lilly, plus new manufacturers projected to enter the market with their own direct-pay GLP-1 options.

The Future: Oral GLP-1s and Market Evolution

Get insights into the next wave of GLP-1 innovations launching in 2025-2026, including oral medications that will make these treatments even more accessible and likely drive utilization growth beyond current projections.

Interested, but can’t attend live? Register to also request access to the full webinar recording.